Literature DB >> 22532249

Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2.

Kangdong Liu1, Chanmi Park, Shengqing Li, Ki Won Lee, Haidan Liu, Long He, Nak Kyun Soung, Jong Seog Ahn, Ann M Bode, Ziming Dong, Bo Yeon Kim, Zigang Dong.   

Abstract

Phosphatidylinositol 3-kinase (PI3-K) amplification and phosphatase and tensin homolog (PTEN) deletion-caused Akt activation contribute to the development of prostate cancer. Mammalian target of rapamycin complex 2 (mTORC2) is a kinase complex comprised of mTOR, Rictor, mSin1, mLST8/GβL and PRR5 and functions in the phosphorylation of Akt at Ser473. Herein, we report that mTORC2 plays an important role in PC3 androgen refractory prostate cell proliferation and anchorage-independent growth. Aloe-emodin, a natural compound found in aloe, inhibited both proliferation and anchorage-independent growth of PC3 cells. Protein content analysis suggested that activation of the downstream substrates of mTORC2, Akt and PKCα, was inhibited by aloe-emodin treatment. Pull-down assay and in vitro kinase assay results indicated that aloe-emodin could bind with mTORC2 in cells and inhibit its kinase activity. Aloe-emodin also exhibited tumor suppression effects in vivo in an athymic nude mouse model. Collectively, our data suggest that mTORC2 plays an important role in prostate cancer development and aloe-emodin suppresses prostate cancer progression by targeting mTORC2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532249      PMCID: PMC3405653          DOI: 10.1093/carcin/bgs156

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

1.  Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

Authors:  H Murillo; H Huang; L J Schmidt; D I Smith; D J Tindall
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

2.  mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.

Authors:  Fei Zhang; Xiaofang Zhang; Menghui Li; Peng Chen; Bin Zhang; Hua Guo; Wenfeng Cao; Xiying Wei; Xuchen Cao; Xishan Hao; Ning Zhang
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

3.  7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase.

Authors:  Dong Eun Lee; Ki Won Lee; Nu Ry Song; Sang Kwon Seo; Yong-Seok Heo; Nam Joo Kang; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

4.  Activation of mTORC2 by association with the ribosome.

Authors:  Vittoria Zinzalla; Daniele Stracka; Wolfgang Oppliger; Michael N Hall
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events.

Authors:  Laia Agell; Silvia Hernández; Marta Salido; Silvia de Muga; Nuria Juanpere; Montserrat Arumí-Uria; Silvia Menendez; Marta Lorenzo; José A Lorente; Sergio Serrano; Josep Lloreta
Journal:  Mod Pathol       Date:  2010-11-26       Impact factor: 7.842

6.  Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors.

Authors:  T Pecere; M V Gazzola; C Mucignat; C Parolin; F D Vecchia; A Cavaggioni; G Basso; A Diaspro; B Salvato; M Carli; G Palù
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

7.  IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.

Authors:  Xiaoduo Xie; Denghong Zhang; Bin Zhao; Min-Kan Lu; Ming You; Gianluigi Condorelli; Cun-Yu Wang; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

8.  Genetic alterations in the PI3K pathway in prostate cancer.

Authors:  Xiuju Sun; Jian Huang; Taku Homma; Daisuke Kita; Helmut Klocker; Georg Schafer; Peter Boyle; Hiroko Ohgaki
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

9.  Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo.

Authors:  Didier Roulin; Yannick Cerantola; Anne Dormond-Meuwly; Nicolas Demartines; Olivier Dormond
Journal:  Mol Cancer       Date:  2010-03-12       Impact factor: 27.401

Review 10.  Role of the Akt pathway in prostate cancer.

Authors:  Paul L de Souza; Pamela J Russell; John Kearsley
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

View more
  17 in total

1.  [MicroRNA-152 and microRNA-448 inhibit proliferation of colorectal cancer cells in vitro by targeting Rictor].

Authors:  Jie Zhang; Zengsheng Han; Lixin Dong; Zhen Li; Kun Li; Ming Shi; Zhiwei Liu; Jian Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

2.  Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.

Authors:  Xiaobin Chang; Jimin Zhao; Fang Tian; Yanan Jiang; Jing Lu; Junfen Ma; Xiaoyan Zhang; Guoguo Jin; Youtian Huang; Zigang Dong; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-07-25       Impact factor: 2.967

3.  Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo.

Authors:  Hua Xie; Mee-Hyun Lee; Feng Zhu; Kanamata Reddy; Zunnan Huang; Dong Joon Kim; Yan Li; Cong Peng; Do Young Lim; Soouk Kang; Sung Keun Jung; Xiang Li; Haitao Li; Weiya Ma; Ronald A Lubet; Jian Ding; Ann M Bode; Zigang Dong
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

4.  Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy.

Authors:  Hong Liu; Liu-bao Gu; Yue Tu; Hao Hu; Yan-ru Huang; Wei Sun
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

5.  A Small Molecule Screen Exposes mTOR Signaling Pathway Involvement in Radiation-Induced Apoptosis.

Authors:  Elizabeth R Sharlow; Stephanie Leimgruber; Ana Lira; Michael J McConnell; Andrés Norambuena; George S Bloom; Michael W Epperly; Joel S Greenberger; John S Lazo
Journal:  ACS Chem Biol       Date:  2016-03-14       Impact factor: 5.100

6.  Anti-cancer effects of aloe-emodin: a systematic review.

Authors:  Brian Sanders; Anna M Ray; Sharon Goldberg; Tyler Clark; H Reginald McDaniel; Steven E Atlas; Ashar Farooqi; Janet Konefal; Lucas C Lages; Johanna Lopez; Ammar Rasul; Eduard Tiozzo; Judi M Woolger; John E Lewis
Journal:  J Clin Transl Res       Date:  2017-09-07

7.  Antiproliferative Activity of Hypericum perforatum, Achillea millefolium, and Aloe vera in Interaction with the Prostatic Activity of CD82.

Authors:  Motahare-Sadat Hosseini; Fatemehsadat Hosseini; Abdolreza Ahmadi; Masoud Mozafari; Issa Amjadi
Journal:  Rep Biochem Mol Biol       Date:  2019-10

Review 8.  Aloe and its Effects on Cancer: A Narrative Literature Review.

Authors:  Astère Manirakiza; Laurent Irakoze; Sebastien Manirakiza
Journal:  East Afr Health Res J       Date:  2021-06-11

9.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Authors:  Jennifer L Bishop; Daksh Thaper; Amina Zoubeidi
Journal:  Cancers (Basel)       Date:  2014-04-09       Impact factor: 6.639

10.  Effects of Free Anthraquinones Extract from the Rhubarb on Cell Proliferation and Accumulation of Extracellular Matrix in High Glucose Cultured-Mesangial Cells.

Authors:  Jianyun Wang; Hui Fang; Bingzheng Dong; Dongdong Wang; Yan Li; Xiao Chen; Lijuan Chen; Tong Wei; Qunli Wei
Journal:  Korean J Physiol Pharmacol       Date:  2015-10-16       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.